GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sprint Bioscience SPRINT.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

4.05

+1.25%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 167.2m

FY2016FY2025

Net income

SEK 91.7m

FY2016FY2025

Free cash flow

SEK 83.4m

FY2016FY2025

Shareholders' equity

SEK 119.2m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 167.2mSEK 65.6mSEK 50.5mSEK 35.1mSEK 16.9mSEK 33.5mSEK 17.9mSEK 24.0mSEK 35.0m
Research and development————————SEK 2.9m
Operating incomeSEK 97.3m−SEK 19.7m−SEK 845,000−SEK 25.5m−SEK 38.8m−SEK 20.3m−SEK 22.1m−SEK 10.7mSEK 4.6m
Net incomeSEK 91.7m−SEK 18.3m−SEK 438,000−SEK 25.4m−SEK 46.2m−SEK 22.7m−SEK 22.2m−SEK 10.7mSEK 4.5m
Diluted earnings per share0.87-0.26-0.01-0.31-2.62-1.84-1.93-1.320.58

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 136.7mSEK 42.1mSEK 62.4mSEK 79.1mSEK 33.4mSEK 19.2mSEK 59.3mSEK 35.5mSEK 49.5m
Cash and short-term investmentsSEK 126.7mSEK 25.1mSEK 49.9mSEK 70.6mSEK 27.1mSEK 8.4mSEK 14.7mSEK 1.5mSEK 23.6m
Total liabilitiesSEK 17.5mSEK 32.8mSEK 34.6mSEK 8.7mSEK 24.3mSEK 8.2mSEK 22.0mSEK 7.4mSEK 21.0m
Debt——SEK 12.3m—SEK 10.0m—SEK 12.0m—SEK 769,231
Shareholders' equitySEK 119.2mSEK 9.3mSEK 27.8mSEK 70.5mSEK 9.1mSEK 11.0mSEK 37.2mSEK 28.1mSEK 28.5m
Shares outstanding106m70m70m81m18m12m12m8m8m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsSEK 83.5m−SEK 23.4mSEK 22.9m−SEK 40.1m−SEK 32.2m−SEK 28.0m−SEK 19.1m−SEK 23.1mSEK 7.9m
Capital spending−SEK 94,000−SEK 1.3m−SEK 2.5m−SEK 2.7m−SEK 2.7m−SEK 93,000−SEK 11.1m−SEK 8.6m−SEK 9.9m
Free cash flowSEK 83.4m−SEK 24.7mSEK 20.4m−SEK 42.8m−SEK 34.9m−SEK 28.1m−SEK 30.2m−SEK 31.6m−SEK 2.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue——SEK 133.9mSEK 5.2mSEK 13.9mSEK 14.1mSEK 16.3mSEK 14.8m
Operating income−SEK 16.6m−SEK 14.3mSEK 117.5m−SEK 8.4m−SEK 6.7m−SEK 4.9m−SEK 4.9m−SEK 5.4m
Net income−SEK 16.2m−SEK 12.9mSEK 113.2m−SEK 8.4m−SEK 7.4m−SEK 5.6m−SEK 4.2m−SEK 5.2m
Diluted earnings per share-0.15-0.121.07-0.08-0.07-0.05-0.06-0.07
Cash from operations−SEK 13.0m−SEK 19.0mSEK 115.0m−SEK 13.0m−SEK 12.0m−SEK 5.0m−SEK 6.0m−SEK 4.0m
Total assetsSEK 104.3mSEK 119.0mSEK 136.7mSEK 21.4mSEK 38.6mSEK 33.8mSEK 42.1mSEK 46.0m
Cash and short-term investmentsSEK 93.3mSEK 108.3mSEK 126.7mSEK 10.9mSEK 24.7mSEK 18.8mSEK 25.1mSEK 31.7m
Shareholders' equitySEK 90.1mSEK 106.3mSEK 119.2mSEK 6.1mSEK 14.3mSEK 3.6mSEK 9.3mSEK 13.5m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue1162.9%58.2%36.0%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin33.4%5.6%-14.4%-24.7%
Net margin31.6%4.5%-17.5%-27.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings1.7-3.5-160.4-0.3-3.6-0.7-1.4-2.2-3.511.1
Price to sales0.91.01.4187.92.61.80.92.71.61.4

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.